טוען...
Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders
Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine)...
שמור ב:
| הוצא לאור ב: | Br J Psychiatry |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cambridge University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7190394/ https://ncbi.nlm.nih.gov/pubmed/32270760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjp.2020.84 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|